Search clinical trials for: Volixibat

Total 8 results

Mirum Pharmaceuticals, Inc.

Terminated

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis

United States, United Kingdom, Canada, Puerto Rico
Mirum Pharmaceuticals, Inc.

Completed

Safety and Tolerability Study of SHP626 in Overweight and Obese Adults

Non-Alcoholic Steatohepatitis

United States
Mirum Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) (VISTAS)

Primary Sclerosing Cholangitis

United States, United Kingdom, Israel, Germany, Canada
Bayer

Completed

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

Canada, France, Germany, United States, Netherlands, United Kingdom
Mirum Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (VANTAGE)

Primary Biliary Cholangitis | PBC

United States, United Kingdom, Israel, Germany, Italy, France
Mirum Pharmaceuticals, Inc.

Terminated

A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA) (OHANA)

Intrahepatic Cholestasis of Pregnancy

United States, United Kingdom, New Zealand
Mirum Pharmaceuticals, Inc.

Completed

A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose

Non-Alcoholic Steatohepatitis

United States
Mirum Pharmaceuticals, Inc.

Completed

Study to Assess the Relative Potency of Multiple Oral Doses of LUM001 and SHP626 in Overweight and Obese Adults as Assessed by Fecal Bile Acid Excretion

Healthy Volunteers

United States

3

Subscribe